Roundtable Discussion: Leveraging CRISPR-Cas9 for Target Discovery & Validation in Oncology
Time: 12:00 pm
day: Conference Day 2
Details:
- In Vivo CRISPR sxreens for target identification to uncover novel oncology and immuno-oncology targets
- Advantages and disadvantages of using CRISPR for target validation
